Your session is about to expire
← Back to Search
New Labeling/Dosing Strategy for Medication Errors
N/A
Waitlist Available
Led By H. Shonna Yin, MD, MS
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up target within 2 weeks after medication course completion
Awards & highlights
Study Summary
This trial is testing strategies to improve labeling and dosing instructions for liquid medications given to children, in order to reduce medication errors and adverse drug events.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ target within 2 weeks after medication course completion
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~target within 2 weeks after medication course completion
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Medication dosing accuracy
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: New Labeling/Dosing StrategyExperimental Treatment1 Intervention
Parents whose children are prescribed liquid medication and meet inclusion/exclusion criteria will receive medications with health literacy informed labels and dosing instruments
Group II: Standard PracticeActive Control1 Intervention
Parents whose children are prescribed medication and meet inclusion/exclusion criteria will fill their medication at their regular pharmacy and receive medication with labeling and dosing instruments as per routine
Find a Location
Who is running the clinical trial?
Stanford UniversityOTHER
2,387 Previous Clinical Trials
17,333,045 Total Patients Enrolled
Emory UniversityOTHER
1,636 Previous Clinical Trials
2,559,568 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,951,574 Total Patients Enrolled
1 Trials studying Medication Errors
600 Patients Enrolled for Medication Errors
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are the parent or legal guardian of a child who is 8 years old or younger.The person responsible for you (parent or legal guardian) is 18 years or older.A child who needs urgent medical attention and is taken to the emergency room.A child who is currently taking a short-term liquid antibiotic.The parents or guardians of the participant should be able to speak either English or Spanish.A parent or caregiver must give the medication to the child.This is a study to test how well the treatment works (Phase II).
Research Study Groups:
This trial has the following groups:- Group 1: Standard Practice
- Group 2: New Labeling/Dosing Strategy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many places are involved in the execution of this research endeavor?
"Participants for this research project can be recruited from 4 different sites, located in Chicago, Stanford, New york and other locations. To lessen the burden of travel on potential enrollees it is wise to select a site closest to your own location."
Answered by AI
Is this trial actively enlisting participants at the present time?
"Unfortunately, this medical study is no longer available to new participants. Initially posted on April 22nd 2013 and last edited on August 30th 2022, it has since been superseded by two other studies that are actively recruiting patients."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger